Scientists have figured out how the new weight-loss drug, Retatrutide, works at a molecular level
NK cell-derived exosomes carry miR-207 and alleviate depression-like symptoms in mice
Beyond weight regain, stopping GLP-1 and GIP/GLP-1 medications triggers several physiological changes that patients should anticipate
Numerous studies prove that BPC-157 accelerates the healing of injuries while it protects and repairs your whole body from normal wear and tear, including the brain, digestive system, cardiovascular system, and even your tendons
"Nutritional priorities to support GLP-1 therapy for obesity," *Obesity* the joint advisory of the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society, which proposes 1.21.6 g/kg during active weight reduction on GLP-1 therapy